OXIS INTERNATIONAL

Company

GT Biopharma, Inc.

Filed

August 14, 2001

Accession Number

0001123274-01-500010

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →